ProKidney Corp. (PROK)
1.83
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 10, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
ProKidney Total Assets (Quarterly) : 249.02M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 249.02M |
| March 31, 2026 | 292.78M |
| December 31, 2025 | 335.57M |
| September 30, 2025 | 351.61M |
| June 30, 2025 | 372.13M |
| March 31, 2025 | 406.06M |
| December 31, 2024 | 442.14M |
| September 30, 2024 | 474.79M |
| June 30, 2024 | 499.16M |
| March 31, 2024 | 387.76M |
| December 31, 2023 | 420.55M |
| Date | Value |
|---|---|
| September 30, 2023 | 451.81M |
| June 30, 2023 | 484.22M |
| March 31, 2023 | 495.15M |
| December 31, 2022 | 518.00M |
| September 30, 2022 | 532.44M |
| June 30, 2022 | 251.00M |
| March 31, 2022 | 250.75M |
| December 31, 2021 | 40.30M |
| September 30, 2021 | 251.44M |
| June 30, 2021 | 0.6228M |
| March 31, 2021 | 0.0251M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.18M |
| Shareholders Equity (Quarterly) | -883.53M |
| Debt to Equity Ratio | -0.004 |
| Current Ratio | 8.356 |
| Net Debt Paydown Yield | -0.01% |